Biotech · Private company
Peel Therapeutics Inc
Track this companyFree. Adds Peel Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- FOLF+BPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PEEL-224Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- PEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsPHASE1_PHASE2 · RECRUITING · started Mar 23, 2025ClinicalTrials.gov NCT06721689 · fetched Nov 12, 2026
- Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory SarcomasPHASE1_PHASE2 · RECRUITING · started Jan 27, 2025ClinicalTrials.gov NCT06709495 · fetched Nov 12, 2026
- A Study to Evaluate PEEL-224 in Patients With Advanced Solid TumorsPHASE1 · RECRUITING · started Jul 11, 2022ClinicalTrials.gov NCT05329103 · fetched Nov 12, 2026